ER
MYOK

Enlightenment Research’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Enlightenment Research’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$20K – 778
2018
Q4 		$20K Buy
+400
New +$22K 0.02% 465

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Enlightenment Research's MYOK Position: Q1 2019 in Review

Enlightenment Research sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2019, closing a stake of 400 shares — an estimated $20K sold.

Enlightenment Research first reported a position in MYOK in Q4 2018 and held it in 1 quarter. The position peaked at $20K in Q4 2018. 169 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • Enlightenment Research reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 400 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $20K.
  • Enlightenment Research first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's MyoKardia, Inc. Common Stock position peaked at $20K in Q4 2018.
  • 169 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.